Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LECANEMAB-IRMB vs LENIOLISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LECANEMAB-IRMB vs LENIOLISIB: Safety Overview

Metric LECANEMAB-IRMB LENIOLISIB
Total FAERS Reports 2,469 570
Deaths Reported 82 6
Death Rate 3.3% 1.1%
Hospitalizations 474 54
Average Patient Age 74.1 yrs 19.4 yrs
% Female Patients 58.6% 27.3%
FDA Approval Date N/A Mar 24, 2023
Manufacturer Eisai Inc. Pharming Healthcare Inc.
Route N/A ORAL
Marketing Status Prescription Prescription